Healthy Adult Volunteers Clinical Trial
Official title:
Effects of Sulforaphane Containing Supplements on Nasal Cell Phase 2 Gene Expression in Healthy Volunteers.
Purpose: To compare the change in nasal cell HO-1 expression induced by two different preparations of sulforaphane (SFN)-containing nutritional supplements Participants: Healthy nonsmoking young adults, age 18-35 Procedures (methods): This pilot study will use a randomized crossover design. Subjects will be randomized to receive either the equivalent of 4 ounces/day of fresh broccoli sprouts (FBS) in food and tea, or the equivalent amount as broccoli sprout homogenates (BSH), for 3 consecutive days. Nasal lavage and blood samples will be obtained before, during and after this 3-day period. After at least a 2-week washout interval, the protocol will be repeated with the alternate supplement. The primary analysis will test the hypothesis that broccoli sprouts in food will increase HO-1 expression to a similar degree as the equivalent amount of sprouts in BSH
Broccoli sprouts are a concentrated source of the potent phase 2 enzyme (antioxidant) potentiator, sulforaphane (SFN) in the form of its natural precursor, sulforaphane glucosinolate (SGS™). SFN is an isothiocyanate which has generated interest recently as a chemopreventive agent in cancer research, and as an antioxidant in inflammation research. Recently published data show that 3 days intake of broccoli sprouts in homogenate form is followed by significant upregulation of several phase 2 enzymes in nasal cells. Our group's research at the UNC Center for Environmental Medicine, Asthma and Lung Biology (CEMALB) focuses on the effects of oxidant pollutants on inflammatory and host defense responses to viral infections. One of the aims of our grant is to measure the effects of pre-treatment with SFN supplements, on nasal responses to live attenuated influenza virus vaccines. In preparation for this larger study, we here propose a pilot study comparing the effects of the published BSH supplement, vs. supplementation with foods containing fresh broccoli sprouts, on relevant nasal endpoints and serum SFN levels. ;
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06034899 -
A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants
|
Phase 1 | |
| Completed |
NCT05162274 -
Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.
|
Phase 1 | |
| Completed |
NCT03748758 -
Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
|
Phase 1 | |
| Recruiting |
NCT06008652 -
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers
|
Phase 1 | |
| Terminated |
NCT02079480 -
Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01657838 -
Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects
|
Phase 1 | |
| Completed |
NCT01651325 -
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects
|
Phase 1 | |
| Completed |
NCT01354379 -
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer
|
Phase 1 | |
| Completed |
NCT04856969 -
Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers
|
Phase 1 | |
| Completed |
NCT01333462 -
Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008
|
Phase 1 | |
| Completed |
NCT02942771 -
A MAD Study of TT301/MW189 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02822898 -
Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults
|
Phase 4 | |
| Completed |
NCT05017987 -
Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012
|
Phase 1 | |
| Not yet recruiting |
NCT05757596 -
Study of VSA001 Injection in Chinese Healthy Adult Volunteers
|
Phase 1 | |
| Completed |
NCT05074368 -
Efficacy and Safety of Heterologous and Homologous COVID-19 Vaccination
|
N/A | |
| Completed |
NCT01672242 -
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
|
N/A | |
| Completed |
NCT03878693 -
4-methylpyrazole and Acetaminophen Metabolism
|
Early Phase 1 | |
| Completed |
NCT04204772 -
A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers
|
Early Phase 1 | |
| Completed |
NCT05154461 -
Intestinal Ketone Bodies Interfere With the Glycemic Control
|
N/A | |
| Active, not recruiting |
NCT02058472 -
Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers
|
Phase 1 |